Apollo Speciality Hospitals, Madurai successfully carried out an ABO‑incompatible living‑donor kidney transplant using antigen‑specific immunoadsorption. The technique lowered the recipient’s antibody titre, enabling a safe transplant from his A‑positive wife to the O‑positive patient.
- ABO‑incompatible kidney transplant performed successfully in Madurai
- Antigen‑specific immunoadsorption reduced anti‑A antibodies dramatically
- 40‑year‑old O‑positive patient received kidney from his A‑positive wife
Apollo Speciality Hospitals in Madurai has performed an ABO‑incompatible living‑donor kidney transplantation using advanced antigen‑specific immunoadsorption therapy. The 40‑year‑old O‑positive recipient received a kidney from his A‑positive wife, marking a milestone in transplant medicine.
Procedure Details
Consultant Nephrologist P. Arun Prasath explained that ABO‑incompatible transplantation demands meticulous immunological preparation, especially when the recipient has a high antibody titre. In this case, the patient’s anti‑A titre was reduced from 1:256 to 1:8 using targeted immunoadsorption, allowing the surgery to proceed safely.
Medical Significance
Traditional plasma exchange posed challenges, but antigen‑specific immunoadsorption selectively removed anti‑A antibodies while returning treated plasma to the patient. This personalized desensitisation not only lowered antibody levels but also facilitated close monitoring of the patient’s overall clinical condition.
Why This Matters
BozokMedia analysis shows that such personalised desensitisation strategies can dramatically expand the donor pool in regions with high ABO‑incompatibility rates, offering hope to thousands of patients awaiting transplants in India.
"Immunoadsorption provides a targeted method to remove antibodies, significantly improving transplant success rates," noted the specialist.
Frequently Asked Questions
Q1: What is an ABO‑incompatible transplant?
A: It is a procedure where a donor’s kidney is transplanted despite differing blood groups, requiring advanced methods to reduce recipient antibodies.
Q2: How does immunoadsorption work?
A: The process filters the patient’s plasma to selectively remove specific antibodies and then returns the cleaned plasma back to the bloodstream.